These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 34844982)
1. Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy. Rusilowicz-Jones EV; Barone FG; Lopes FM; Stephen E; Mortiboys H; Urbé S; Clague MJ Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34844982 [TBL] [Abstract][Full Text] [Related]
2. Novel highly selective inhibitors of ubiquitin specific protease 30 (USP30) accelerate mitophagy. Kluge AF; Lagu BR; Maiti P; Jaleel M; Webb M; Malhotra J; Mallat A; Srinivas PA; Thompson JE Bioorg Med Chem Lett; 2018 Aug; 28(15):2655-2659. PubMed ID: 29935771 [TBL] [Abstract][Full Text] [Related]
3. Dual role of USP30 in controlling basal pexophagy and mitophagy. Marcassa E; Kallinos A; Jardine J; Rusilowicz-Jones EV; Martinez A; Kuehl S; Islinger M; Clague MJ; Urbé S EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29895712 [TBL] [Abstract][Full Text] [Related]
4. Deubiquitinating enzyme USP30 maintains basal peroxisome abundance by regulating pexophagy. Riccio V; Demers N; Hua R; Vissa M; Cheng DT; Strilchuk AW; Wang Y; McQuibban GA; Kim PK J Cell Biol; 2019 Mar; 218(3):798-807. PubMed ID: 30700497 [TBL] [Abstract][Full Text] [Related]
5. USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation. Rusilowicz-Jones EV; Jardine J; Kallinos A; Pinto-Fernandez A; Guenther F; Giurrandino M; Barone FG; McCarron K; Burke CJ; Murad A; Martinez A; Marcassa E; Gersch M; Buckmelter AJ; Kayser-Bricker KJ; Lamoliatte F; Gajbhiye A; Davis S; Scott HC; Murphy E; England K; Mortiboys H; Komander D; Trost M; Kessler BM; Ioannidis S; Ahlijanian MK; Urbé S; Clague MJ Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32636217 [TBL] [Abstract][Full Text] [Related]
6. The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy. Bingol B; Tea JS; Phu L; Reichelt M; Bakalarski CE; Song Q; Foreman O; Kirkpatrick DS; Sheng M Nature; 2014 Jun; 510(7505):370-5. PubMed ID: 24896179 [TBL] [Abstract][Full Text] [Related]
7. USP30 deubiquitylates mitochondrial Parkin substrates and restricts apoptotic cell death. Liang JR; Martinez A; Lane JD; Mayor U; Clague MJ; Urbé S EMBO Rep; 2015 May; 16(5):618-27. PubMed ID: 25739811 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological inhibition of USP30 activates tissue-specific mitophagy. Luo H; Krigman J; Zhang R; Yang M; Sun N Acta Physiol (Oxf); 2021 Jul; 232(3):e13666. PubMed ID: 33890401 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease. Miller S; Muqit MMK Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519 [TBL] [Abstract][Full Text] [Related]
10. Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Ordureau A; Paulo JA; Zhang J; An H; Swatek KN; Cannon JR; Wan Q; Komander D; Harper JW Mol Cell; 2020 Mar; 77(5):1124-1142.e10. PubMed ID: 32142685 [TBL] [Abstract][Full Text] [Related]
11. Organelle Turnover: A USP30 Safety Catch Restrains the Trigger for Mitophagy and Pexophagy. Ganley IG Curr Biol; 2018 Aug; 28(15):R842-R845. PubMed ID: 30086320 [TBL] [Abstract][Full Text] [Related]
12. Investigation of USP30 inhibition to enhance Parkin-mediated mitophagy: tools and approaches. Tsefou E; Walker AS; Clark EH; Hicks AR; Luft C; Takeda K; Watanabe T; Ramazio B; Staddon JM; Briston T; Ketteler R Biochem J; 2021 Dec; 478(23):4099-4118. PubMed ID: 34704599 [TBL] [Abstract][Full Text] [Related]
13. New aspects of USP30 biology in the regulation of pexophagy. Marcassa E; Kallinos A; Jardine J; Rusilowicz-Jones EV; Clague MJ; Urbé S Autophagy; 2019 Sep; 15(9):1634-1637. PubMed ID: 31356149 [TBL] [Abstract][Full Text] [Related]
14. The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013. Ferrer S; Muratore ME; Buijnsters P Expert Opin Ther Pat; 2022 May; 32(5):523-559. PubMed ID: 34743664 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of mitophagy: PINK1, Parkin, USP30 and beyond. Bingol B; Sheng M Free Radic Biol Med; 2016 Nov; 100():210-222. PubMed ID: 27094585 [TBL] [Abstract][Full Text] [Related]
16. USP30-AS1 contributes to mitochondrial quality control in glioblastoma cells. Wang N; Li J; Xin Q; Xu N Biochem Biophys Res Commun; 2021 Dec; 581():31-37. PubMed ID: 34653676 [TBL] [Abstract][Full Text] [Related]
17. Identification of an autoinhibitory, mitophagy-inducing peptide derived from the transmembrane domain of USP30. Qin X; Wang R; Xu H; Tu L; Chen H; Li H; Liu N; Wang J; Li S; Yin F; Xu N; Li Z Autophagy; 2022 Sep; 18(9):2178-2197. PubMed ID: 34989313 [TBL] [Abstract][Full Text] [Related]
18. Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson's disease mouse model. Fang TZ; Sun Y; Pearce AC; Eleuteri S; Kemp M; Luckhurst CA; Williams R; Mills R; Almond S; Burzynski L; Márkus NM; Lelliott CJ; Karp NA; Adams DJ; Jackson SP; Zhao JF; Ganley IG; Thompson PW; Balmus G; Simon DK Nat Commun; 2023 Nov; 14(1):7295. PubMed ID: 37957154 [TBL] [Abstract][Full Text] [Related]
19. Mechanism and regulation of the Lys6-selective deubiquitinase USP30. Gersch M; Gladkova C; Schubert AF; Michel MA; Maslen S; Komander D Nat Struct Mol Biol; 2017 Nov; 24(11):920-930. PubMed ID: 28945249 [TBL] [Abstract][Full Text] [Related]
20. USP30: Structure, Emerging Physiological Role, and Target Inhibition. Wang F; Gao Y; Zhou L; Chen J; Xie Z; Ye Z; Wang Y Front Pharmacol; 2022; 13():851654. PubMed ID: 35308234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]